2,110 results on '"Kim, Sung Bae"'
Search Results
202. Trastuzumab emtansine versus treatment of physician's choice for pretreated HER2-positive advanced breast cancer (TH3RESA): a randomised, open-label, phase 3 trial
203. Changes in serum hydroxyvitamin D levels of breast cancer patients during tamoxifen treatment or chemotherapy in premenopausal breast cancer patients
204. Prognostic factors in patients with head and neck squamous cell carcinoma with cN3 neck disease: a retrospective case-control study
205. A phase Ia/Ib study of novel anti‐ErbB3 monoclonal antibody, barecetamab (ISU104) in refractory solid cancers and monotherapy or in combination with cetuximab in recurrent or metastatic head and neck cancer.
206. Elucidating therapeutic molecular targets in premenopausal Asian women with recurrent breast cancers
207. Enhancement of the Enzymatic Digestibility of Waste Newspaper Using Tween
208. Edge Detection Using a Complex-Valued Directional Vector Representation
209. Inhibition of lysine acetyltransferase KAT6 in ER+HER2−metastatic breast cancer: a phase 1 trial
210. Phase II trial of neoadjuvant letrozole and lapatinib in Asian postmenopausal women with estrogen receptor (ER) and human epidermal growth factor receptor 2 (HER2)-positive breast cancer [Neo-ALL-IN]: Highlighting the TILs, ER expressional change after neoadjuvant treatment, and FES-PET as potential significant biomarkers
211. Experimental study on structural performance of the new shaped weak-axis connection in full-scale test
212. Experimental study on bending behavior and seismic performance of hybrid composite beam with new shape
213. Effect of polypharmacy and potentially inappropriate medications on treatment and posttreatment courses in elderly patients with head and neck cancer
214. Influence of annealing atmosphere on the electrical conductivity of copper nanoparticle films
215. Flexural behavior of an alternative lath mortar deck plate
216. C-Series Coelenterazine-Driven Bioluminescence Signature Imaging
217. Role of Esophagectomy after Chemoradiation Therapy in Patients with Locally Advanced Squamous Cell Carcinoma: A Comparative Analysis Stratified by Clinical Response to Chemoradiation Therapy
218. Randomized phase III trial of a neoadjuvant regimen of four cycles of adriamycin plus cyclophosphamide followed by four cycles of docetaxel (AC4-D4) versus a shorter treatment of three cycles of FEC followed by three cycles of docetaxel (FEC3-D3) in node-positive breast cancer (Neo-Shorter; NCT02001506)
219. Cost-effectiveness of palbociclib in early breast cancer patients with a high risk of relapse: Results from the PENELOPE-B trial
220. T cell-inflamed gene expression profile and PD-L1 expression and pembrolizumab efficacy in advanced esophageal cancer
221. Treatment With Adjuvant Abemaciclib Plus Endocrine Therapy in Patients With High-risk Early Breast Cancer Who Received Neoadjuvant Chemotherapy
222. Enhancement of Enzymatic Digestibility of Recycled Newspaper by Addition of Surfactant in Ammonia-Hydrogen Peroxide Pretreatment
223. A phase two randomised trial of neratinib monotherapy versus lapatinib plus capecitabine combination therapy in patients with HER2+ advanced breast cancer
224. Improved tolerance of recombinant Escherichia coli to the toxicity of crude glycerol by overexpressing trehalose biosynthetic genes (otsBA) for the production of β-carotene
225. Synergistic antibacterial effect of curcumin against methicillin-resistant Staphylococcus aureus
226. Enzymatic Digestibility of Used Newspaper Treated with Aqueous Ammonia-Hydrogen Peroxide Solution
227. Evaluation of the Fire Resistance Performance and the Post-Fire Structural Performance for CFT Columns with Square-Shape Steel Tube
228. Effect of Pretreatment Reagent and Hydrogen Peroxide on Enzymatic Hydrolysis of Oak in Percolation Process
229. Quality of life on TSU‐68: Combination of docetaxel and TSU‐68, an oral antiangiogenic agent, in patients with metastatic breast cancer previously treated with anthracycline
230. Predictive factors for long-term survival in head and neck squamous cell carcinoma patients with distant metastasis after initial definitive treatment
231. Salvage Esophagectomy for Locoregional Failure After Chemoradiotherapy in Patients With Advanced Esophageal Cancer
232. A prospective multicentre phase II study of cisplatin and weekly docetaxel as first-line treatment for recurrent or metastatic nasopharyngeal cancer (KCSG HN07-01)
233. An experimental study on structural performance evaluation of steel wire-integrated deck plate
234. Cation-driven Optical Properties of Artificial Luciferases
235. Tau and PTEN status as predictive markers for response to trastuzumab and paclitaxel in patients with HER2-positive breast cancer
236. Intratumor Textural Heterogeneity on Pretreatment 18F-FDG PET Images Predicts Response and Survival After Chemoradiotherapy for Hypopharyngeal Cancer
237. Quality of life (QoL) in metastatic breast cancer patients with maintenance paclitaxel plus gemcitabine (PG) chemotherapy: results from phase III, multicenter, randomized trial of maintenance chemotherapy versus observation (KCSG-BR07-02)
238. Oncologic Outcomes According to Remnant Lymph Node Metastases in Pathologic T0 (ypT0) Esophageal Squamous Cell Carcinoma Following Prospective Neoadjuvant Therapy and Surgery
239. Translation and validation of Korean Functional Assessment of Cancer Therapy-Esophageal (FACT-E) scale with squamous cell carcinoma and chemoradiation-only patients
240. Subcutaneous versus intravenous administration of (neo)adjuvant trastuzumab in patients with HER2-positive, clinical stage I–III breast cancer (HannaH study): a phase 3, open-label, multicentre, randomised trial
241. Laryngeal edema after radiotherapy in patients with squamous cell carcinomas of the larynx and hypopharynx
242. Enhanced production of trehalose in Escherichia coli by homologous expression of otsBA in the presence of the trehalase inhibitor, validamycin A, at high osmolarity
243. Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer
244. PS2-1 Trastuzumab deruxtecan vs T-DM1 in HER2+ mBC in Asian subgroup: Results of the randomized phase 3 study DESTINY-Breast03
245. Analysis of Legal Cases on Veterans and Compensation for Military deaths and Accidents
246. Trastuzumab deruxtecan (T-DXd) versus trastuzumab emtansine (T-DM1) in patients (pts) with HER2-positive (HER2+) unresectable and/or metastatic breast cancer (mBC): Safety follow-up of the randomized, phase 3 study DESTINY-Breast03.
247. A phase 3, randomized, open-label study of the anti-Globo H vaccine adagloxad simolenin/obi-821 in the adjuvant treatment of high-risk, early-stage, Globo H-positive triple-negative breast cancer.
248. Phase II study of trastuzumab-pkrb and docetaxel anhydrous combination therapy in recurrent or metastatic salivary ductal carcinomas (KCSG HN18-08/KM11).
249. Phase 1b/2 study of GX-I7 plus pembrolizumab in patients with refractory or recurrent (R/R) metastatic triple-negative breast cancer (mTNBC): The KEYNOTE-899 Study.
250. Randomized, phase 3 study of second-line tislelizumab vs chemotherapy in advanced or metastatic esophageal squamous cell carcinoma, RATIONALE 302: Asia subgroup.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.